Start
Entdecken
nav.journalClub
Trends
Mehr
synapse
⌘+K
Sprache
Deutsch
Navigating the United States FDA advisory: Probiotics in Preterm Infants | Synapse
March 3, 2026
Navigating the United States FDA advisory: Probiotics in Preterm Infants
SV
S. Viswanathan
Nemours Children's Clinic
KG
Kanekal Suresh Gautham
Key Points
Probiotics may help improve gut microbiota in preterm infants, enhancing their immune response.
Research shows a 30% reduction in risks associated with gastrointestinal issues in preterm infants receiving probiotics.
Observational analysis of guidelines and existing data reveals inconsistencies in FDA's probiotic recommendations.
Regulatory clarity is needed to maximize the benefits of probiotics for vulnerable preterm infants.
Mark Helpful
Like
Save
Bookmark
Relay
Share
Mark Helpful
Like
Save
Bookmark
Relay
Share
Cite This Study
Copy
Viswanathan et al. (Tue,) studied this question.
synapsesocial.com/papers/69a760b9c6e9836116a2dbe1
https://doi.org/https://doi.org/10.1038/s41372-026-02574-4